Physician profile
Matthew D Weldon
NPI 1467712174
$61,772.67
in general payments reported to CMS, 2019-2025
31 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $4,184 · 2021: $5,271 · 2022: $5,451 · 2023: $4,342 · 2024: $11K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Travel and Lodging: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17,217.45 |
| Travel and Lodging | $14,670.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,555.82 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, T2 |
| Smith+Nephew, INC. | $13,730.47 | 2019-2025 | Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Medinc of Texas | $10,078.57 | 2019-2025 | |
| Arthrex, INC. | $7,689.85 | 2021-2025 | Extremities & Trauma Implants Long Bone Trauma Trochanteric Fracture, Arthrex, Distal Extremities Implants Trauma |
| Djo, LLC | $3,711.25 | 2019 | |
| Encore Medical, LP | $1,613.67 | 2025 | |
| Exactech, INC. | $1,519.39 | 2019-2023 | |
| Globus Medical, INC. | $939.53 | 2024-2025 | Senza, A/R Femoral Nail, Arbor |
| Fx Shoulder Solutions, INC | $718.13 | 2024-2025 | |
| Depuy Synthes Sales INC. | $471.04 | 2019-2025 | Monovisc, Orthovisc |
| Linvatec Corporation | $469.24 | 2023-2025 | Biobrace 23mm |
| Innovation Technologies INC | $362.89 | 2021-2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $244.70 | 2019-2025 | Osseofit |
| Miach Orthopaedics, INC. | $192.49 | 2024 | |
| Conformis, INC. | $174.02 | 2023 | Itotal Identity Cruciate Retaining Knee Replacement System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $166.77 | 2020-2024 | Maci |
| Orthalign INC | $148.60 | 2021 | |
| Amgen INC. | $139.95 | 2024 | Evenity |
| Biocomposites INC | $134.38 | 2025 | Stimulan |
| Skeletal Dynamics INC | $127.84 | 2024 | Ijs, Geminus, Align |
| Nalu Medical, INC. | $103.46 | 2025 | Nalu Neurostimulation System |
| Ossur Americas, INC. | $88.78 | 2025 | |
| Medacta USA, INC. | $73.63 | 2023 | Mecta |
| Catalyst Orthoscience | $62.44 | 2021 | |
| Becton, Dickinson and Company | $58.09 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $56.59 | 2023 | Swiftset |
| Acumed LLC | $51.90 | 2025 | Acumed |
| Ferring Pharmaceuticals INC. | $30.69 | 2020 | |
| Trimed, INC. | $23.92 | 2023 | |
| Ethicon US, LLC | $19.11 | 2025 | Stratafix, Ethicon, Dermabond Prineo |
| Molnlycke Health Care US, LLC | $15.46 | 2023 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Weldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.